Deals
Bid & Ask
This article is for subscribers only.
1. DuPont (DD) upped its bid for the Danish food ingredients maker Danisco to $6.7 billion after an initial takeover bid failed to win sufficient investor support.
2. Israel's Teva Pharmaceutical Industries (TEVA), the world's No. 1 generic drug company, agreed to pay $6.2 billion for Cephalon (CEPH), which is developing stem cell treatments and therapies for asthma and lung cancer.
